Bnp Paribas Asset Management Holding S.A. Incyte Corp Transaction History

Bnp Paribas Asset Management Holding S.A.

$40.3 Billion
Q4 2024

A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Incyte Corp stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 14,848 shares of INCY stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,848

Previous 20,280 26.79%

Holding current value

$1.06 Million

Previous $1.34 Million 23.49%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$65.08 - $83.38 $353,514 - $452,920	-5,432 Reduced 26.79%	14,848 $1.03 Million
Q3 2024 Nov 08, 2024	SELL	$57.33 - $68.61 $3.41 Million - $4.08 Million	-59,448 Reduced 74.56%	20,280 $1.34 Million
Q2 2024 Jul 29, 2024	BUY	$51.18 - $63.75 $2.89 Million - $3.59 Million	56,370 Added 241.33%	79,728 $4.83 Million
Q1 2024 May 08, 2024	SELL	$56.55 - $66.59 $218,961 - $257,836	-3,872 Reduced 14.22%	23,358 $1.33 Million
Q4 2023 Feb 09, 2024	BUY	$52.16 - $64.19 $104,945 - $129,150	2,012 Added 7.98%	27,230 $1.71 Million
Q3 2023 Nov 13, 2023	BUY	$57.77 - $65.93 $290,352 - $331,364	5,026 Added 24.89%	25,218 $1.46 Million
Q2 2023 Aug 08, 2023	SELL	$60.95 - $75.51 $273,421 - $338,737	-4,486 Reduced 18.18%	20,192 $1.26 Million
Q1 2023 May 08, 2023	BUY	$70.23 - $86.01 $115,949 - $142,002	1,651 Added 7.17%	24,678 $1.78 Million
Q4 2022 Feb 09, 2023	BUY	$67.18 - $84.11 $24,655 - $30,868	367 Added 1.62%	23,027 $1.85 Million
Q3 2022 Nov 10, 2022	BUY	$66.18 - $82.86 $254,991 - $319,259	3,853 Added 20.49%	22,660 $1.51 Million
Q2 2022 Aug 04, 2022	BUY	$66.18 - $83.18 $199,665 - $250,954	3,017 Added 19.11%	18,807 $1.43 Million
Q1 2022 May 12, 2022	BUY	$66.02 - $79.71 $433,817 - $523,774	6,571 Added 71.28%	15,790 $1.25 Million
Q4 2021 Feb 09, 2022	SELL	$63.34 - $74.11 $372,249 - $435,544	-5,877 Reduced 38.93%	9,219 $677,000
Q3 2021 Nov 08, 2021	SELL	$68.67 - $84.02 $151,211 - $185,012	-2,202 Reduced 12.73%	15,096 $1.04 Million
Q2 2021 Aug 05, 2021	BUY	$79.87 - $87.53 $153,110 - $167,795	1,917 Added 12.46%	17,298 $1.46 Million
Q1 2021 May 05, 2021	SELL	$76.02 - $100.5 $1,368 - $1,809	-18 Reduced 0.12%	15,381 $1.25 Million
Q4 2020 Feb 12, 2021	BUY	$80.74 - $97.7 $135,481 - $163,940	1,678 Added 12.23%	15,399 $1.34 Million
Q3 2020 Nov 09, 2020	SELL	$85.07 - $109.69 $1.72 Million - $2.22 Million	-20,229 Reduced 59.58%	13,721 $1.23 Million
Q2 2020 Aug 04, 2020	SELL	$74.18 - $108.93 $5.77 Million - $8.47 Million	-77,769 Reduced 69.61%	33,950 $3.53 Million
Q1 2020 May 12, 2020	BUY	$63.18 - $85.97 $3.14 Million - $4.27 Million	49,629 Added 79.93%	111,719 $8.18 Million
Q4 2019 Feb 11, 2020	SELL	$73.04 - $95.72 $1.4 Million - $1.83 Million	-19,104 Reduced 23.53%	62,090 $5.42 Million
Q3 2019 Nov 12, 2019	SELL	$72.82 - $86.52 $3.21 Million - $3.81 Million	-44,078 Reduced 35.19%	81,194 $6.03 Million
Q2 2019 Aug 02, 2019	BUY	$73.52 - $88.7 $126,380 - $152,475	1,719 Added 1.39%	125,272 $10.6 Million
Q1 2019 Apr 26, 2019	BUY	$63.56 - $88.17 $7.54 Million - $10.5 Million	118,574 Added 2381.48%	123,553 $10.6 Million
Q4 2018 Feb 13, 2019	BUY	$58.5 - $69.94 $16,146 - $19,303	276 Added 5.87%	4,979 $310,000
Q3 2018 Nov 13, 2018	SELL	$61.75 - $74.23 $6,113 - $7,348	-99 Reduced 2.06%	4,703 $325,000
Q2 2018 Aug 01, 2018	BUY	$60.85 - $83.98 $72,837 - $100,524	1,197 Added 33.2%	4,802 $322,000
Q1 2018 May 07, 2018	SELL	$83.06 - $100.98 $2.46 Million - $2.99 Million	-29,644 Reduced 89.16%	3,605 $300,000
Q4 2017 Feb 01, 2018	SELL	$93.56 - $116.6 $1.5 Million - $1.87 Million	-16,042 Reduced 32.55%	33,249 $3.15 Million
Q3 2017 Nov 02, 2017	BUY	$109.15 - $138.27 $5.38 Million - $6.82 Million	49,291	49,291 $5.75 Million

Others Institutions Holding INCY

# of Institutions

706

Shares Held

189M

Call Options Held

909K

Put Options Held

489K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.

Account

Bnp Paribas Asset Management Holding S.A. Incyte Corp Transaction History